Exforge HCT

amlodipine/valsartan/hydrochlorothiazide · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Exforge HCT, covering 2009-04-30 to 2026-02-06. Get the full timeline:

Most recent: EMA Authorised: Exforge HCT (valsartan;hydrochlorothiazide;amlodipine besilate) — Novartis Europharm Limited